Meet the therapy changing brain cancer treatment. 🧠 Dr. Simon Hanft and the team at WMCHealth helped lead the Phase III ROADS trial studying GammaTile therapy, delivering radiation directly at the surgical site instead of making patients wait weeks for treatment. The results: a greater than 50% reduction in risk of recurrence or death. 🔗 Link in bio to learn more about this incredible milestone. #WMCHealth #GammaTile #BrainCancerAwareness #NeurosurgicalOncology #ClinicalTrial #Innovation #HudsonValley